Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DD52FT
|
|||
| Drug Name |
AVT001
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Type-1 diabetes [ICD-11: 5A10] | Phase 1/2 | [1] | |
| Company |
Avotres
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03895996) A Phase 1 / 2 Double-Blind, Randomized, Placebo Controlled Study of Safety, Tolerability and Potential Efficacy of AVOTRES Cell-Based Therapy (AVT001) in Patients With Type 1 Diabetes. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.